Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Telapristone Acetate

    ACTIVE PHARMA INGREDIENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Repros Therapeutics (RPRX) Boss Steps Down, Interim CEO Named
    Repros Therapeutics (RPRX) Boss Steps Down, Interim CEO Named

    02 Feb 2017

    // Mark Terry BIOSPACE

    http://www.biospace.com/News/repros-therapeutics-boss-steps-down-interim-ceo/445713/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

    Mark Terry BIOSPACE
    02 Feb 2017
    Share Share
    FDA Grants End of Phase 2 Meeting to Discuss Ph3 Requirements for Oral Proellex
    FDA Grants End of Phase 2 Meeting to Discuss Ph3 Requirements for Oral Proellex

    30 Jan 2017

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2017/01/30/912009/0/en/FDA-Grants-End-of-Phase-2-Meeting-to-Discuss-Phase-3-Requirements-for-Oral-Proellex-in-the-Treatment-of-Uterine-Fibroids.html

    GLOBENEWSWIRE
    30 Jan 2017
    Share Share
    Repros Requests Meeting With FDA to Discuss Ph3 Requirements for Proellex
    Repros Requests Meeting With FDA to Discuss Ph3 Requirements for Proellex

    19 Dec 2016

    // GLOBENEWSWIRE

    https://globenewswire.com/news-release/2016/12/19/898955/0/en/Repros-Requests-Meeting-With-FDA-to-Discuss-Phase-3-Requirements-for-Proellex-in-the-Treatment-of-Endometriosis.html

    GLOBENEWSWIRE
    19 Dec 2016
    Share Share
    Repros to drop testosterone drug in U.S. if key study fails
    Repros to drop testosterone drug in U.S. if key study fails

    15 Apr 2016

    // Amrutha Penumudi REUTERS

    http://www.reuters.com/article/us-repros-study-idUSKCN0XB2IK

    Amrutha Penumudi REUTERS
    15 Apr 2016
    Share Share